LSB Industries, Inc. Schedules 2025 Second Quarter Results Release for Tuesday, July 29
LSB's management will host a conference call on Wednesday, July 30, 2025 at 10:00 am ET / 9:00 am CT to discuss these results. Participating in the call will be Chairman, President & Chief Executive Officer, Mark Behrman, Executive Vice President & Chief Financial Officer, Cheryl Maguire and Executive Vice President & Chief Commercial Officer, Damien Renwick. Interested parties may participate in the call by dialing (877) 407-6176 / (201) 689-8451. Please call in 10 minutes before the conference is scheduled to begin and ask for the LSB Industries conference call. Following the prepared remarks, there will be a question and answer session.
A webcast of the call, along with a slide presentation that coincides with management's prepared remarks, will be available in the Investors section of LSB's website, at www.lsbindustries.com. The webcast can be found under Events & Presentations. If you are unable to listen to the live call, the conference call webcast will be archived on LSB's website.
About LSB Industries, Inc.
LSB Industries, Inc., headquartered in Oklahoma City, Oklahoma, is committed to playing a leadership role in the production of low and no carbon products that build, feed and power the world. The LSB team is dedicated to building a culture of excellence in customer experiences as we currently deliver essential products across the industrial and agricultural end markets and, in the future, the energy markets. The company manufactures ammonia and ammonia-related products at facilities in Cherokee, Alabama, El Dorado, Arkansas and Pryor, Oklahoma and operates a facility for a global chemical company in Baytown, Texas. Additional information about LSB can be found on our website at www.lsbindustries.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Bernstein Reiterates Outperform on TSMC (TSM), Citing Strategic Chip Role
Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM) is one of the best growth stocks to buy according to analysts. On August 15, Bernstein reiterated its Outperform rating on Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), with a price target of $249.00. That represents an implied upside of only 4.1% from the current price of $239.1. A close-up of a complex network of integrated circuits used in logic semiconductors. However, Bernstein cited the Taiwanese company's strategic importance in the global semiconductor landscape, emphasizing that it accounts for roughly 15–25% of the worldwide wafer fab equipment (WFE) market. That is massive, especially considering the whole of China's share of 30–40%. Bernstein also cited that a significant share of the company's capital expenditures is allocated beyond just traditional wafer fabrication. According to the firm, TSMC is increasingly investing higher amounts in infrastructure, packaging, and testing technologies. These are critical components in advanced chip production. Last month, the company delivered a stellar Q2 2025 performance, with revenue climbed to NT$933.79 billion (US $30.07 billion), up 38.6 % year-over-year; while net income reached NT$398.27 billion (about US $13.53 billion), and diluted EPS came in at NT$15.36 (US $2.47 per ADR), a whopping 60.7 % jump year-over-year. While we acknowledge the potential of TSM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
38 minutes ago
- Yahoo
Novo Nordisk A/S (NVO) Delivers 18% Sales Growth in H1 2025
Novo Nordisk A/S (NYSE:NVO) is one of the Reddit Stocks with the Highest Upside Potential. On August 6, the company stated that it delivered 18% sales growth in H1 2025. The company has lowered its full-year outlook because of lower growth expectations for its GLP-1 treatments in H2 2025. Therefore, it has been taking measures to sharpen its commercial execution further, and ensure efficiencies in its cost base while continuing to make investments in future growth. With over 1 billion people living with obesity globally, which includes over 100 million living in the US, and only a few million on treatment, Novo Nordisk A/S (NYSE:NVO) expects to maximise the strong growth opportunities, thanks to the healthy product portfolio and future pipeline. A closeup shot of a laboratory technician handling a medical device used for fertility treatments. Novo Nordisk A/S (NYSE:NVO) highlighted that the sales within Diabetes and Obesity care rose 16% in Danish kroner to DKK 145.4 billion (and 18% at CER), mainly due to the Obesity care growth of 56% in Danish kroner to DKK 38.8 billion (and 58% at CER) and GLP-1 diabetes sales increasing 8% in Danish kroner (10% at CER). Within R&D, Novo Nordisk A/S (NYSE:NVO) plans to advance subcutaneous and oral amycretin into phase 3 development in weight management on the basis of completed clinical studies during Q1 2025. For FY 2025, the sales growth is anticipated to be 8% – 14% at CER, and operating profit growth is projected to be 10% – 16% at CER. ClearBridge Investments, an investment management company, released its Q1 2025 investor letter. Here is what the fund said: 'We initiated a new position in Novo Nordisk A/S (NYSE:NVO), the global leader in diabetes care and one of two dominant players in the fast-growing GLP-1 diabetes and obesity drug market. A slowdown in prescriptions for Novo's GLP-1 drugs, combined with confusion surrounding a clinical trial of its next-generation candidate, CagriSema, caused a significant pullback in the stock. We saw this as a buying opportunity. We believe the GLP-1 market remains vast and that Novo (alongside Eli Lilly) is well-positioned to maintain a duopolistic structure for years to come, given the complexity of manufacturing, differentiated intellectual property and brand strength. We also expect growth to reaccelerate as supply ramps up following its acquisition of Catalent and as regulators crack down on unlicensed compounders.' While we acknowledge the potential of NVO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
38 minutes ago
- Yahoo
Needham Maintains Buy Rating on The Walt Disney Company (DIS) Stock
The Walt Disney Company (NYSE:DIS) is one of the Reddit Stocks with the Highest Upside Potential. On August 7, Laura Martin from Needham maintained a 'Buy' rating on the company's stock, with a price objective of $125.00. The analyst's rating is backed by several positive developments for The Walt Disney Company (NYSE:DIS) in Q3 2025. Notably, the company's diluted EPS rose to $2.92 from $1.43 in Q3 2024, and adjusted EPS went up by 16% for Q3 2025 to $1.61 from $1.39 in Q3 2024. A packed theater of moviegoers watching a blockbuster film produced by the entertainment company. Furthermore, The Walt Disney Company (NYSE:DIS)'s direct-to-consumer segment demonstrated profitability with an operating income of $346 million. The company's Experiences segment saw operating income of $2.5 billion, reflecting a rise of $294 million compared to Q3 2024. The operating income in the quarter demonstrates a ~$40 million benefit from the timing of the Easter holiday, and a ~$30 million impact from pre-opening expenses at Disney Cruise Line. Despite the concerns, the positive financial performance and strategic initiatives, like asset swap involving ESPN and the NFL Network, as well as the timely launch of ESPN's flagship service, supported the analyst's rating. Diamond Hill Capital, an investment management company, released its Q1 2025 investor letter. Here is what the fund said: 'Other top Q2 contributors included The Walt Disney Company (NYSE:DIS), Ferguson Enterprises and Capital One Financial. Diversified media and entertainment company Walt Disney benefited from easing macroeconomic concerns, primarily in its parks division, which is particularly sensitive to the economic backdrop.' While we acknowledge the potential of DIS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
